Literature DB >> 19726876

Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.

Yukiko K Hayashi1, Chie Matsuda, Megumu Ogawa, Kanako Goto, Kayo Tominaga, Satomi Mitsuhashi, Young-Eun Park, Ikuya Nonaka, Naomi Hino-Fukuyo, Kazuhiro Haginoya, Hisashi Sugano, Ichizo Nishino.   

Abstract

Caveolae are invaginations of the plasma membrane involved in many cellular processes, including clathrin-independent endocytosis, cholesterol transport, and signal transduction. They are characterized by the presence of caveolin proteins. Mutations that cause deficiency in caveolin-3, which is expressed exclusively in skeletal and cardiac muscle, have been linked to muscular dystrophy. Polymerase I and transcript release factor (PTRF; also known as cavin) is a caveolar-associated protein suggested to play an essential role in the formation of caveolae and the stabilization of caveolins. Here, we identified PTRF mutations in 5 nonconsanguineous patients who presented with both generalized lipodystrophy and muscular dystrophy. Muscle hypertrophy, muscle mounding, mild metabolic complications, and elevated serum creatine kinase levels were observed in these patients. Skeletal muscle biopsies revealed chronic dystrophic changes, deficiency and mislocalization of all 3 caveolin family members, and reduction of caveolae structure. We generated expression constructs recapitulating the human mutations; upon overexpression in myoblasts, these mutations resulted in PTRF mislocalization and disrupted physical interaction with caveolins. Our data confirm that PTRF is essential for formation of caveolae and proper localization of caveolins in human cells and suggest that clinical features observed in the patients with PTRF mutations are associated with a secondary deficiency of caveolins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726876      PMCID: PMC2735915          DOI: 10.1172/JCI38660

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

Review 2.  Emerging themes in lipid rafts and caveolae.

Authors:  F Galbiati; B Razani; M P Lisanti
Journal:  Cell       Date:  2001-08-24       Impact factor: 41.582

3.  Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.

Authors:  R C Betz; B G Schoser; D Kasper; K Ricker; A Ramírez; V Stein; T Torbergsen; Y A Lee; M M Nöthen; T F Wienker; J P Malin; P Propping; A Reis; W Mortier; T J Jentsch; M Vorgerd; C Kubisch
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

4.  Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.

Authors:  Y Sunada; H Ohi; A Hase; H Ohi; T Hosono; S Arata; S Higuchi; K Matsumura; T Shimizu
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

5.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

6.  Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

Authors:  J Magré; M Delépine; E Khallouf; T Gedde-Dahl; L Van Maldergem; E Sobel; J Papp; M Meier; A Mégarbané; A Bachy; A Verloes; F H d'Abronzo; E Seemanova; R Assan; N Baudic; C Bourut; P Czernichow; F Huet; F Grigorescu; M de Kerdanet; D Lacombe; P Labrune; M Lanza; H Loret; F Matsuda; J Navarro; A Nivelon-Chevalier; M Polak; J J Robert; P Tric; N Tubiana-Rufi; C Vigouroux; J Weissenbach; S Savasta; J A Maassen; O Trygstad; P Bogalho; P Freitas; J L Medina; F Bonnicci; B I Joffe; G Loyson; V R Panz; F J Raal; S O'Rahilly; T Stephenson; C R Kahn; M Lathrop; J Capeau
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

7.  Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

Authors:  Babak Razani; Terry P Combs; Xiao Bo Wang; Philippe G Frank; David S Park; Robert G Russell; Maomi Li; Baiyu Tang; Linda A Jelicks; Philipp E Scherer; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

8.  AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.

Authors:  Anil K Agarwal; Elif Arioglu; Salome De Almeida; Nurullah Akkoc; Simeon I Taylor; Anne M Bowcock; Robert I Barnes; Abhimanyu Garg
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

9.  Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.

Authors:  Carlo Minetti; Massimo Bado; Paolo Broda; Federica Sotgia; Claudio Bruno; Ferruccio Galbiati; Daniela Volonte; Giuseppe Lucania; Antonio Pavan; Eduardo Bonilla; Michael P Lisanti; Giuseppe Cordone
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

10.  Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia.

Authors:  Henian Cao; Lindsay Alston; Jennifer Ruschman; Robert A Hegele
Journal:  Lipids Health Dis       Date:  2008-01-31       Impact factor: 3.876

View more
  155 in total

Review 1.  The dynamic roles of intracellular lipid droplets: from archaea to mammals.

Authors:  Denis J Murphy
Journal:  Protoplasma       Date:  2011-10-15       Impact factor: 3.356

2.  Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis.

Authors:  Weihua Fei; Hui Li; Guanghou Shui; Tamar S Kapterian; Christopher Bielby; Ximing Du; Andrew J Brown; Peng Li; Markus R Wenk; Pingsheng Liu; Hongyuan Yang
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

Review 3.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

4.  Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation.

Authors:  Joe Swift; Irena L Ivanovska; Amnon Buxboim; Takamasa Harada; P C Dave P Dingal; Joel Pinter; J David Pajerowski; Kyle R Spinler; Jae-Won Shin; Manorama Tewari; Florian Rehfeldt; David W Speicher; Dennis E Discher
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

5.  The Puzzling Conservation and Diversification of Lipid Droplets from Bacteria to Eukaryotes.

Authors:  Josselin Lupette; Eric Maréchal
Journal:  Results Probl Cell Differ       Date:  2020

6.  Muscle choline kinase beta defect causes mitochondrial dysfunction and increased mitophagy.

Authors:  Satomi Mitsuhashi; Hideyuki Hatakeyama; Minako Karahashi; Tomoko Koumura; Ikuya Nonaka; Yukiko K Hayashi; Satoru Noguchi; Roger B Sher; Yasuhito Nakagawa; Giovanni Manfredi; Yu-ichi Goto; Gregory A Cox; Ichizo Nishino
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

Review 7.  What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Authors:  Camille Vatier; Guillaume Bidault; Nolwenn Briand; Anne-Claire Guénantin; Laurence Teyssières; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

Review 8.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

Review 9.  Lipodystrophy syndromes.

Authors:  Pedro Herranz; Raul de Lucas; Luis Pérez-España; Matias Mayor
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

10.  Caveolae and lipid trafficking in adipocytes.

Authors:  Paul F Pilch; Tova Meshulam; Shiying Ding; Libin Liu
Journal:  Clin Lipidol       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.